Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.
about
Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesMolecular adjuvant interleukin-33 enhances the antifertility effect of Lagurus lagurus zona pellucida 3 DNA vaccine administered by the mucosal routeMolecular mechanisms for enhanced DNA vaccine immunogenicity.The promise of chitosan microspheres in drug delivery systems.Polymeric Materials for Gene Delivery and DNA VaccinationNanomedicine in pulmonary deliveryFate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitro.Antitubercular inhaled therapy: opportunities, progress and challenges.Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheresAirway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity.The performance of nanocarriers for transmucosal drug delivery.Pulmonary vaccine delivery.DNA vaccines against mycobacterial diseases.Nanoparticles and microparticles as vaccine-delivery systems.Design of nanoparticle-based dry powder pulmonary vaccines.Is intranasal vaccination a feasible solution for tuberculosis?Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles.Bioadhesive delivery systems for mucosal vaccine delivery.Pharmaceutical aerosols for the treatment and prevention of tuberculosisNanocarriers targeting dendritic cells for pulmonary vaccine delivery.Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.Plant-based vaccines against respiratory diseases: current status and future prospects.Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers.Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes.Oral gene application using chitosan-DNA nanoparticles induces transferable tolerance.Influence of the chitosan nature on the transfection efficacy of DNA-loaded nanoparticles after hydrodynamic administration in mice.Enhanced protection against pulmonary mycobacterial challenge by chitosan-formulated polyepitope gene vaccine is associated with increased pulmonary secretory IgA and gamma-interferon(+) T cell responses.Toxicological evaluation of lactose and chitosan delivered by inhalation.Self-Assembled Hydrogel Nanoparticles for Drug Delivery Applications.Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review.A Potential Nanomedicine Consisting of Heparin-Loaded Polysaccharide Nanocarriers for the Treatment of AsthmaDNA vaccines against tuberculosisDNA vaccines against mycobacterial diseasesChitosan nanoparticles: a contribution to nanomedicineTranslating chitosan to clinical delivery of nucleic acid-based drugs
P2860
Q28294355-838BC792-FFD1-44D3-86D8-060E9C21AE9FQ28658606-E2E79C9C-A02E-438B-9FAB-56F15B351BB2Q30366743-F033C6D7-4154-4D43-8D96-C1EBB4E00985Q31112020-59DF0993-56A5-4D96-8D87-CAD67A236C57Q33565296-C7ED5CA7-CA91-4B38-A4D2-1C6C21ADF4BCQ33572981-027337DE-15BB-4D87-8558-8780DAFFA458Q34960453-ACF95971-99D2-4665-8854-C4FA814609BEQ36068001-2990174C-6C80-4FC0-8D11-3D68848C1B2BQ36276099-A6C583A6-10E1-4159-BA80-0E96938B5D17Q36499684-61103031-7057-45B9-822B-E80AB3892A81Q36527739-7D6F27D1-9E3F-41B7-BE1A-8D6F2FB2775EQ36780141-A2927684-277B-4DAE-BFD6-B1A299B9BCBFQ36895737-5E287E90-F02E-4F2C-8787-18992064569BQ36968297-9FD0FECF-4A35-4BDB-B3B3-8BE01AA929E3Q36985908-2FA38144-4209-45F8-BD72-758255AEDA4EQ37316013-330460E0-DB5F-442E-8513-A54EC7CAB09EQ37730793-5A217B2C-6102-4296-A257-55275602C95AQ37805519-FDBD27EB-7662-499D-831B-69A7FF29F02DQ38042953-E49886CE-BDB6-47A8-8E5F-7EBE994DB02EQ38051096-FB4EB746-C9BC-447D-BB9D-E40714C7E73EQ38152851-7B904591-B133-4F9C-89DC-26738DBC36F6Q38418305-69A5B0D2-0F3C-4CD4-A5E7-CE9AA11B02F9Q38823962-755E63FB-6E83-4176-99B2-185058A21650Q38903481-C9143F0A-F6D2-4DDE-9C01-97B36B665D8EQ39810464-862D9BE1-4E1D-492F-A854-F530DDB19BB3Q40447732-C70EA54E-B6B0-402A-84B9-74E46B160963Q41426532-1997963A-5536-4210-9D82-49B8F6D2B072Q43161884-60337AC0-C318-4502-8910-7448557DF63AQ43838346-E171A984-EA28-44E9-9F48-FBAEAB6829B4Q46714930-34547983-6491-46FA-ACC9-DCCD425CA0CAQ47098115-86DC457E-1EBF-4E7A-837E-8DF2464BB009Q49874317-99ECCBFC-C187-47D8-B840-5062F02F5D1CQ56992635-8AB6D8CB-9321-442E-AC23-389D8E1A5659Q57203104-8350FE94-04E5-473D-98C1-25EF38481E4EQ57203115-0159ED1F-3926-4C1B-A449-026FF665CF8DQ57342948-0D3C0581-DBC4-42A7-8886-CAC00B187D44Q57556362-397F4635-3F73-48CD-95E8-59BA5DC27F20
P2860
Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Pulmonary delivery of chitosan ...... of Mycobacterium tuberculosis.
@en
Pulmonary delivery of chitosan ...... of Mycobacterium tuberculosis.
@nl
type
label
Pulmonary delivery of chitosan ...... of Mycobacterium tuberculosis.
@en
Pulmonary delivery of chitosan ...... of Mycobacterium tuberculosis.
@nl
prefLabel
Pulmonary delivery of chitosan ...... of Mycobacterium tuberculosis.
@en
Pulmonary delivery of chitosan ...... of Mycobacterium tuberculosis.
@nl
P2093
P1433
P1476
Pulmonary delivery of chitosan ...... of Mycobacterium tuberculosis.
@en
P2093
Annemieke Geluk
Gerrit Borchard
Hans E Junginger
Kees L M C Franken
Krista E van Meijgaarden
Maytal Bivas-Benita
Tom H M Ottenhoff
P304
P356
10.1016/J.VACCINE.2003.09.044
P407
P577
2004-04-01T00:00:00Z